Budesonide Monoclonal Antibody

Cat.#: 176733

Size:

Special Price 322.6 USD

Availability: In Stock
- +

Add to cart to get an online quotation

Product Information

  • Product Name
    Budesonide Monoclonal Antibody
  • Documents
  • Description
    Product has been tested in direct ELISA.
  • Tested applications
    ELISA
  • Species reactivity
    Chemical
  • Isotype
    Mouse IgG1, κ
  • Preparation
    Budesonide conjugated with BSA. Protein G affinity purified
  • Clonality
    Monoclonal
  • Formulation
    PBS(pH7.4), lyophilized. Reconstitution: Adding sterile water, prepare a stock solution of 2.0 mg/ml.
  • Storage instructions
    Store at -20℃. Avoid freeze / thaw cycles.
  • Applications
    ELISA: 1:5,000-1:20,000
  • Validations

    ELISA Binding Assay of Anti- Budesonide Antibody to different proteins.

    ELISA Binding Assay of Anti- Budesonide Antibody to different proteins.

    ELISA analysis of Anti-Budesonide Monoclonal Antibody with Budesonide-BSA, Budesonide-OVA, BSA, OVA and Budesonide ADC. Anti-Budesonide Monoclonal Antibody can bind to Budesonide-BSA, Budesonide-OVA or Budesonide ADC but not carrier proteins.

    ELISA Binding Assay of Anti- Budesonide Antibody

    ELISA Binding Assay of Anti- Budesonide Antibody

    Immobilized Budesonide ADC at 2μg/ /mL (100μL/well) can bind anti-Budesonide mouse monoclonal antibody.

  • Background
    Budesonide is a potent corticosteroid medication renowned for its efficacy in managing inflammatory diseases affecting both the airways and gastrointestinal tract. This glucocorticoid exerts its therapeutic effects primarily through topical administration, demonstrating a remarkable ability to alleviate symptoms with less impact on the hypothalamic-pituitary-adrenal axis compared to equivalent doses of oral prednisone. Beyond its traditional uses, budesonide has also found application as a payload in antibody–drug conjugates, underscoring its versatility in combating inflammatory conditions and even cancer. By binding to glucocorticoid receptors, budesonide initiates cascades of gene expression changes that modulate inflammation over varying time frames, making it a cornerstone in the treatment of diverse inflammatory disorders.
  • References
    • Yasir M, Goyal A, Sonthalia S. Corticosteroid Adverse Effects. 2023 Jul 3. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 30285357.
    • Gardill BR, Vogl MR, Lin HY, Hammond GL, Muller YA. Corticosteroid-binding globulin: structure-function implications from species differences. PLoS One. 2012;7(12):e52759. doi: 10.1371/journal.pone.0052759. Epub 2012 Dec 26. PMID: 23300763; PMCID: PMC3530532.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"